Home › Asset managers › Compare 2024-2025 › BlackRock vs Prudential/PGIM
BlackRock 2024-2025 · Prudential/PGIM 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 9,807 | 8,151 | 612 | 1,044 | 93.0% | 88.3% |
| Board proposals | 8,124 | 6,861 | 507 | 756 | 93.1% | 89.1% |
| E&S shareholder proposals | 255 | 153 | 9 | 93 | 94.4% | 80.8% |
| Other items | 1,428 | 1,137 | 96 | 195 | 92.2% | 85.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
756 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Prudential/PGIM |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC. | June 3, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 5 FOR, 26 AGAINST |
AGAINST 1 fund |
| 3D SYSTEMS CORP. | May 16, 2025 | The approval, on an advisory basis, of the compensation paid to our named executive officers in 2024. Say-on-Pay |
Board | For | FOR 14 funds |
Split 1 FOR, 1 AGAINST |
| 3M CO. | May 13, 2025 | Advisory approval of executive compensation. Say-on-Pay |
Board | For | FOR 65 funds |
Split 8 FOR, 10 AGAINST |
| ACADIA HEALTHCARE COMPANY INC. | May 29, 2025 | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement. Say-on-Pay |
Board | For | FOR 43 funds |
Split 1 FOR, 3 AGAINST |
| ACLARIS THERAPEUTICS INC. | June 5, 2025 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card. Say-on-Pay |
Board | For | Split 1 FOR, 4 AGAINST |
Split 1 FOR, 1 AGAINST |
| ADAPTIVE BIOTECHNOLOGIES CORP. | June 10, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement; Say-on-Pay |
Board | For | FOR 22 funds |
Split 2 FOR, 3 AGAINST |
| ADAPTIVE BIOTECHNOLOGIES CORP. | June 10, 2025 | To elect one Class III director nominee to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2028 annual meeting of shareholders; Chad Robins Director Elections |
Board | For | FOR 10 funds |
Split 3 FOR, 1 WITHHOLD |
| ADOBE INC. | April 22, 2025 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 90 funds |
Split 20 FOR, 1 AGAINST |
| ADT INC. | May 21, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 30 funds |
Split 6 FOR, 1 AGAINST |
| ADVANCE AUTO PARTS INC. | May 14, 2025 | Approve, by advisory vote, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 31 funds |
Split 1 FOR, 3 AGAINST |
| ADVANCED MICRO DEVICES INC. | May 14, 2025 | Approve on a non-binding, advisory basis the compensation of the named executive officers, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission. Say-on-Pay |
Board | For | FOR 88 funds |
Split 3 FOR, 14 AGAINST |
| ADVANTAGE SOLUTIONS INC. | May 28, 2025 | To approve, on a advisory (non-binding) basis, the compensation of Advantage Solution Inc.'s named executive officers. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
AGAINST 3 funds |
| ADVERUM BIOTECHNOLOGIES INC. | June 17, 2025 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 10 funds |
Split 1 FOR, 1 AGAINST |
| AES CORP. | May 9, 2025 | Approval of The AES Corporation 2025 Equity and Incentive Compensation Plan. Compensation |
Board | For | FOR 27 funds |
Split 2 FOR, 6 AGAINST |
| AES CORP. | May 9, 2025 | Approval, on an advisory basis, of the Company's executive compensation. Say-on-Pay |
Board | For | FOR 42 funds |
Split 1 FOR, 8 AGAINST |
| AFFIRM HOLDINGS INC CLASS A | June 25, 2025 | To approve the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion. Capital Structure |
Board | For | Split 8 FOR, 18 AGAINST |
AGAINST 2 funds |
| AGCO CORP. | April 24, 2025 | Non-binding advisory resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 40 funds |
Split 6 FOR, 1 AGAINST |
| AGIOS PHARMACEUTICALS INC. | June 18, 2025 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, to increase the number of shares of common stock available thereunder by 2,500,000 shares. Compensation |
Board | For | FOR 16 funds |
Split 2 FOR, 1 AGAINST |
| AGREE REAL | May 15, 2025 | To approve an amendment to our Articles of Incorporation, as amended and supplemented, to increase the number of authorized shares of our common stock. Capital Structure |
Board | Not determined | FOR 29 funds |
Split 5 FOR, 1 AGAINST |
| AGREE REAL | May 15, 2025 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | Not determined | FOR 45 funds |
Split 5 FOR, 2 AGAINST |
| AIR LEASE | May 2, 2025 | Advisory vote to approve named executive officer compensation Say-on-Pay |
Board | Not determined | FOR 33 funds |
Split 1 FOR, 1 AGAINST |
| AIR PRODUCTS AND CHEMICALS INC. | January 23, 2025 | Advisory Vote Approving the Compensation of the Company's Executive Officers. Say-on-Pay |
Board | Contested | FOR 49 funds |
Split 9 FOR, 1 AGAINST |
| AIR PRODUCTS AND CHEMICALS INC. | January 23, 2025 | Ratify the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending September 30, 2025. Audit-related |
Board | Contested | FOR 31 funds |
Split 4 FOR, 5 ABSTAIN |
| AIR TRANSPORT SERVICES GROUP INC. | February 10, 2025 | To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"). Say-on-Pay |
Board | For | FOR 22 funds |
Split 1 FOR, 1 AGAINST |
| AKERO THERAPEUTICS INC. | June 3, 2025 | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 30 funds |
Split 2 FOR, 3 AGAINST |
| ALBEMARLE CORP. | May 6, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 50 funds |
Split 6 FOR, 1 AGAINST |
| ALECTOR INC. | June 11, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 19 funds |
Split 1 FOR, 1 AGAINST |
| ALIGN TECHNOLOGY INC. | May 21, 2025 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | FOR 68 funds |
Split 3 FOR, 6 AGAINST |
| ALLEGIANT TRAVEL CO. | June 26, 2025 | Approval of an amendment to the Allegiant Travel Company 2022 Long-Term Incentive Plan. Compensation |
Board | For | FOR 14 funds |
Split 1 FOR, 1 AGAINST |
| ALLIANZ SE | May 8, 2025 | APPROVE REMUNERATION POLICY Say-on-Pay |
Board | For | Split 4 FOR, 10 AGAINST |
AGAINST 1 fund |
| ALLIENT INC. | May 7, 2025 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 18 funds |
Split 1 FOR, 1 AGAINST |
| ALLOGENE THERAPEUTICS INC. | June 18, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 21 funds |
Split 1 FOR, 1 AGAINST |
| ALLY FINANCIAL INC. | May 6, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 50 funds |
Split 5 FOR, 2 AGAINST |
| ALNYLAM PHARMACEUTICALS | May 8, 2025 | To approve the second amended and restated 2018 Stock Incentive Plan. Compensation |
Board | For | FOR 42 funds |
Split 10 FOR, 1 AGAINST |
| ALPINE INCOME PROPERTY TRUST INC. | May 21, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 1 fund |
| ALTRIA GROUP INC. | May 15, 2025 | Approval of the 2025 Performance Incentive Plan Compensation |
Board | For | FOR 41 funds |
Split 1 FOR, 15 AGAINST |
| ALX ONCOLOGY HOLDINGS INC | June 11, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 1 FOR, 11 AGAINST |
FOR 1 fund |
| AMBARELLA INC. | June 4, 2025 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 27 funds |
Split 1 FOR, 3 AGAINST |
| AMC NETWORKS INC | June 5, 2025 | Vote on Proposal to Approve the Company's Amended and Restated 2016 Employee Stock Plan Compensation |
Board | For | Split 7 FOR, 9 AGAINST |
AGAINST 1 fund |
| AMERANT BANCORP INC. | May 7, 2025 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers - Say-on-Pay. Say-on-Pay |
Board | For | FOR 21 funds |
Split 1 FOR, 1 AGAINST |
| AMERICAN INTERNATIONAL GROUP INC. | May 14, 2025 | Advisory Vote to Approve Named Executive Officer Compensation. Say-on-Pay |
Board | For | FOR 58 funds |
Split 1 FOR, 6 AGAINST |
| AMERICAN WELL CORP (AMWELL) | June 11, 2025 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company's proxy statement. Say-on-Pay |
Board | For | Split 2 FOR, 2 WITHHOLD |
WITHHOLD 1 fund |
| AMERIS BANCORP | June 5, 2025 | Election of Director to serve until the Company's 2026 Annual Meeting: William H. Stern Director Elections |
Board | For | Split 16 FOR, 1 AGAINST |
FOR 6 funds |
| AMERIS BANCORP | June 5, 2025 | Election of Director to serve until the Company's 2026 Annual Meeting: William I. Bowen, Jr. Director Elections |
Board | For | Split 16 FOR, 1 AGAINST |
FOR 6 funds |
| AMPHENOL CORP. | May 15, 2025 | Approval of an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock Capital Structure |
Board | For | FOR 52 funds |
Split 2 FOR, 5 AGAINST |
| AMPLITUDE INC. | June 12, 2025 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 23 funds |
Split 1 FOR, 1 AGAINST |
| AMTECH SYSTEMS INC. | March 5, 2025 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement; and Say-on-Pay |
Board | For | FOR 3 funds |
Split 1 FOR, 1 AGAINST |
| ANALOG DEVICES | March 12, 2025 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 64 funds |
Split 13 FOR, 5 AGAINST |
| ANAPTYSBIO INC. | June 17, 2025 | To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. Say-on-Pay |
Board | For | Split 3 FOR, 22 AGAINST |
AGAINST 1 fund |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock. Capital Structure |
Board | For | FOR 15 funds |
Split 1 FOR, 1 AGAINST |
| ANI PHARMACEUTICALS INC. | May 22, 2025 | To approve the Amended and Restated 2016 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 15 funds |
Split 1 FOR, 1 AGAINST |
| ANIKA THERAPEUTICS INC. | June 20, 2025 | Advisory vote on the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 16 funds |
Split 1 FOR, 1 AGAINST |
| ANNEXON INC. | June 5, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 20 funds |
Split 1 FOR, 1 AGAINST |
| ANYWHERE REAL ESTATE INC. | May 7, 2025 | Approval of the Third Amended and Restated 2018 Long-Term Incentive Plan. Compensation |
Board | For | FOR 11 funds |
Split 2 FOR, 1 AGAINST |
| AON PLC | June 27, 2025 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 70 funds |
Split 2 FOR, 5 AGAINST |
| APA CORP. | May 22, 2025 | Advisory Vote to Approve Compensation of APA's Named Executive Officers Say-on-Pay |
Board | For | FOR 38 funds |
Split 2 FOR, 6 AGAINST |
| API GROUP | May 16, 2025 | To approve the amendment of our certificate of incorporation to increase the number of authorized shares of common stock. Capital Structure |
Board | Not determined | FOR 18 funds |
Split 1 FOR, 1 AGAINST |
| APPLE INC. | February 25, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 107 funds |
Split 20 FOR, 9 AGAINST |
| APPLIED THERAPEUTICS INC. | June 9, 2025 | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials. Say-on-Pay |
Board | For | Split 15 FOR, 1 AGAINST |
FOR 1 fund |
| ARCHER AVIATION INC. | June 27, 2025 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 9 FOR, 22 AGAINST |
Split 3 FOR, 1 AGAINST |
| ARCHER-DANIELS-MIDLAND CO. | May 8, 2025 | Advisory Vote on Executive Compensation. Say-on-Pay |
Board | For | FOR 53 funds |
Split 2 FOR, 7 AGAINST |
| ARCUS BIOSCIENCES INC. | June 10, 2025 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 37 funds |
Split 1 FOR, 2 AGAINST |
| ARES MANAGEMENT CORP. | June 6, 2025 | Approval, on a non-binding, advisory basis, of the compensation paid to our named executive officers for our 2024 fiscal year. Say-on-Pay |
Board | For | AGAINST 48 funds |
Split 4 FOR, 2 AGAINST |
| ARISTA NETWORKS INC. | May 30, 2025 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 16 FOR, 53 AGAINST |
Split 16 FOR, 3 AGAINST |
| ASPEN AEROGELS INC. | April 30, 2025 | Approval of the compensation of Aspen Aerogels, Inc.'s named executive officers, as disclosed in its Proxy Statement for the 2025 Annual Meeting. Say-on-Pay |
Board | For | FOR 22 funds |
Split 1 FOR, 1 AGAINST |
| ASSOCIATED | April 29, 2025 | Approval of the Associated Banc-Corp 2025 Equity Incentive Plan. Compensation |
Board | Not determined | FOR 17 funds |
Split 1 FOR, 3 AGAINST |
| ASTRIA THERAPEUTICS INC. | June 11, 2025 | The approval, by non-binding advisory vote, of our executive compensation. Say-on-Pay |
Board | For | FOR 21 funds |
Split 1 FOR, 1 AGAINST |
| ATLANTIC U | May 6, 2025 | To approve the Atlantic Union Bankshares Corporation 2025 Stock and Incentive Plan Compensation |
Board | Not determined | FOR 14 funds |
Split 3 FOR, 1 AGAINST |
| ATLANTIC U | May 6, 2025 | To approve the compensation of our named executive officers (an advisory, non-binding "Say on Pay" resolution) Say-on-Pay |
Board | Not determined | FOR 26 funds |
Split 3 FOR, 2 AGAINST |
| ATLANTICUS HOLDINGS CORP. | May 8, 2025 | To approve the "say-on-pay" resolution set forth below: RESOLVED, that the shareholders of Atlanticus Holdings Corporation hereby approve, on an advisory basis, the compensation of the company's named executive officers, as disclosed in the company's Proxy Statement for the 2025 Annual Meeting of Shareholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Summary Compensation Table and the other related tables and disclosure. Say-on-Pay |
Board | For | AGAINST 12 funds |
Split 1 FOR, 1 AGAINST |
| ATLAS COPCO A | April 29, 2025 | ACQUIRE CLASS A SHARES RELATED TO PERSONNEL OPTION PLAN Capital Structure |
Board | Not determined | Split 12 FOR, 22 AGAINST |
FOR 5 funds |
| ATLAS COPCO A | April 29, 2025 | APPROVE STOCK OPTION PLAN 2025 FOR KEY EMPLOYEES Compensation |
Board | Not determined | Split 12 FOR, 22 AGAINST |
FOR 5 funds |
| ATLAS COPCO A | April 29, 2025 | REELECT GORDON RISKE AS DIRECTOR Director Elections |
Board | Not determined | Split 12 FOR, 22 AGAINST |
FOR 5 funds |
| ATLAS COPCO A | April 29, 2025 | REELECT HANS STRABERG AS BOARD CHAIR Corporate Governance |
Board | Not determined | AGAINST 34 funds |
Split 4 FOR, 1 AGAINST |
| ATLAS COPCO A | April 29, 2025 | REELECT HANS STRABERG AS DIRECTOR Director Elections |
Board | Not determined | Split 12 FOR, 22 AGAINST |
Split 4 FOR, 1 AGAINST |
| ATLAS COPCO A | April 29, 2025 | REELECT JOHAN FORSSELL AS DIRECTOR Director Elections |
Board | Not determined | FOR 34 funds |
Split 4 FOR, 1 AGAINST |
| ATLAS COPCO A | April 29, 2025 | REELECT PETER WALLENBERG JR AS DIRECTOR Director Elections |
Board | Not determined | Split 12 FOR, 22 AGAINST |
Split 4 FOR, 1 AGAINST |
| ATLAS COPCO A | April 29, 2025 | TRANSFER CLASS A SHARES RELATED TO PERSONNEL OPTION PLAN FOR 2025 Capital Structure |
Board | Not determined | Split 12 FOR, 22 AGAINST |
FOR 5 funds |
| ATLASSIAN CORP PLC | December 11, 2024 | An advisory vote to approve the compensation of our named executive officers for the fiscal year ended June 30, 2024. Say-on-Pay |
Board | Not determined | FOR 65 funds |
Split 7 FOR, 1 AGAINST |
| AVANOS MEDICAL INC. | April 24, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 26 funds |
Split 1 FOR, 5 AGAINST |
| AVANOS MEDICAL INC. | April 24, 2025 | Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares. Compensation |
Board | For | FOR 13 funds |
Split 4 FOR, 1 AGAINST |
| AVID BIOSERVICES INC. | January 30, 2025 | To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Avid's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contentemplated by the Merger Agreement. Say-on-Pay |
Board | For | FOR 21 funds |
Split 1 FOR, 3 AGAINST |
| AVIDITY BIOSCIENCES INC. | June 10, 2025 | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. Say-on-Pay |
Board | For | Split 9 FOR, 22 AGAINST |
AGAINST 4 funds |
| AVITA MEDICAL INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 12 FOR, 1 AGAINST |
AGAINST 1 fund |
| AXON ENTERPRISE INC. | May 29, 2025 | Election of Director: Hadi Partovi Director Elections |
Board | For | Split 12 FOR, 38 AGAINST |
FOR 11 funds |
| AXON ENTERPRISE INC. | May 29, 2025 | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 13 FOR, 52 AGAINST |
Split 8 FOR, 5 AGAINST |
| AXOS FINANCIAL INC. | November 14, 2024 | To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. Say-on-Pay |
Board | For | FOR 30 funds |
Split 1 FOR, 4 AGAINST |
| AXSOME THERAPEUTICS INC. | June 6, 2025 | Election of Director: Roger Jeffs, Ph.D. Director Elections |
Board | For | FOR 18 funds |
Split 2 FOR, 1 WITHHOLD |
| BALDWIN INSURANCE GROUP INC. | June 5, 2025 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 23 funds |
Split 4 FOR, 1 AGAINST |
| BALL CORP. | April 30, 2025 | Approve, by non-binding vote, the compensation paid to the named executive officers. Say-on-Pay |
Board | For | FOR 55 funds |
Split 1 FOR, 13 AGAINST |
| BANC OF CALIFORNIA INC. | May 7, 2025 | Approval, on an advisory and non-binding basis, of the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting (Say-on-Pay). Say-on-Pay |
Board | For | Split 6 FOR, 22 AGAINST |
FOR 4 funds |
| BANDWIDTH INC. | May 29, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 20 funds |
Split 1 FOR, 1 AGAINST |
| BANK OF AMERICA CORP. | April 22, 2025 | Amending and restating the Bank of America Corporation Equity Plan Compensation |
Board | For | FOR 60 funds |
Split 25 FOR, 1 AGAINST |
| BANK OF AMERICA CORP. | April 22, 2025 | Approving our executive compensation (an advisory, non-binding "Say on Pay" resolution) Say-on-Pay |
Board | For | FOR 77 funds |
Split 11 FOR, 11 AGAINST |
| BANK OF HAWAII CORP. | April 25, 2025 | Say on Pay - An advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 28 funds |
Split 1 FOR, 2 AGAINST |
| BANKUNITED INC. | May 22, 2025 | Advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
Split 3 FOR, 5 AGAINST |
| BAXTER INTERNATIONAL INC. | May 6, 2025 | Advisory Vote to Approve Named Executive Officer Compensation for 2024 Say-on-Pay |
Board | For | FOR 56 funds |
Split 2 FOR, 7 AGAINST |
| BAYCOM CORP | June 17, 2025 | An advisory (non-binding) vote on executive compensation. Say-on-Pay |
Board | For | Split 12 FOR, 1 AGAINST |
FOR 3 funds |
| BEACHBODY COMPANY INC. | June 4, 2025 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | Split 2 FOR, 2 AGAINST |
AGAINST 1 fund |
| BERKSHIRE HILLS BANCORP INC. | May 21, 2025 | A proposal to approve an amendment to Berkshire's Certificate of Incorporation to increase the number of authorized shares of common stock of the surviving corporation (the "Berkshire Certificate of Incorporation Amendment Proposal"). Capital Structure |
Board | For | FOR 14 funds |
Split 1 FOR, 3 AGAINST |
Page 1 of 8 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.